Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 26;31(1):25.
doi: 10.1186/s12929-024-01013-w.

Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications

Affiliations
Review

Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications

Shiliang Xu et al. J Biomed Sci. .

Abstract

Breast cancer is one of the most common malignancies that pose a serious threat to women's health. Reprogramming of energy metabolism is a major feature of the malignant transformation of breast cancer. Compared to normal cells, tumor cells reprogram metabolic processes more efficiently, converting nutrient supplies into glucose, amino acid and lipid required for malignant proliferation and progression. Non-coding RNAs(ncRNAs) are a class of functional RNA molecules that are not translated into proteins but regulate the expression of target genes. NcRNAs have been demonstrated to be involved in various aspects of energy metabolism, including glycolysis, glutaminolysis, and fatty acid synthesis. This review focuses on the metabolic regulatory mechanisms and clinical applications of metabolism-regulating ncRNAs involved in breast cancer. We summarize the vital roles played by metabolism-regulating ncRNAs for endocrine therapy, targeted therapy, chemotherapy, immunotherapy, and radiotherapy resistance in breast cancer, as well as their potential as therapeutic targets and biomarkers. Difficulties and perspectives of current targeted metabolism and non-coding RNA therapeutic strategies are discussed.

Keywords: Amino acid metabolism; Breast cancer; Glycolysis; Lipid metabolism; Metabolism; Non-coding RNAs.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Characterization, biogenesis and biology of ncRNAs. Biogenesis of miRNAs, LncRNAs, circRNAs and tsRNAs and the molecular mechanisms of their biological functions
Fig. 2
Fig. 2
Steps in ncRNA-regulated reprogramming of glucose metabolism in breast cancer by glycolysis, lactate formation, glycogen synthesis and catabolism and the tricarboxylic acid cycle. Blue boxes and arrows represent positive regulations, while red boxes and lines with blunt ends represent negative regulations
Fig. 3
Fig. 3
Steps in ncRNA-regulated reprogramming of fatty acid synthesis, β-oxidation, cholesterol synthesis and phospholipid metabolism in breast cancer. Blue boxes and arrows represent positive regulations, while red boxes and lines with blunt ends represent negative regulations. Dashed lines indicate omitted steps
Fig. 4
Fig. 4
Steps in ncRNA-regulated reprogramming of amino acid metabolism. Blue boxes and arrows represent positive regulations, while red boxes and lines with blunt ends represent negative regulations
Fig. 5
Fig. 5
Clinical implications of non-coding RNAs and metabolism in breast cancer

Similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. - PubMed
    1. Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321:288–300. - PubMed
    1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. - PubMed
    1. Paul S, Ghosh S, Kumar S. Tumor glycolysis, an essential sweet tooth of tumor cells. Semin Cancer Biol. 2022;86:1216–1230. - PubMed
    1. Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134:703–707. - PubMed